Fluvastatin sodium 80 extended release tablet en
Fluvastatin sodium extended release tablet, for oral administration, consisting of: 80mg/tablet fluvastatin sodium.Indications:LESCOL/LESCOL XL is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia (1.1)Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy (1.1)Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD (1.2)Slow the progression of atherosclerosis in patients with CHD (1.2)Limitations of Use: Neither LESCOL nor LESCOL XL have been studied in conditions where the major abnormality is elevation of chylomicrons, VLDL, or IDL (i.e., hyperlipoproteinemia Types I, III, IV, or V) (1.3) [ - ]
Links
| Subject | Predicate | Object/Value | Creator | Attribution | Timestamp | |
|---|---|---|---|---|---|---|
| 1 | /m/0hqrswg | /common/topic/description | Fluvastatin sodium extended release tablet, for oral administration, consisting of: 80mg/tablet fluvastatin sodium.Indications:LESCOL/LESCOL XL is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia (1.1)Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy (1.1)Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD (1.2)Slow the progression of atherosclerosis in patients with CHD (1.2)Limitations of Use: Neither LESCOL nor LESCOL XL have been studied in conditions where the major abnormality is elevation of chylomicrons, VLDL, or IDL (i.e., hyperlipoproteinemia Types I, III, IV, or V) (1.3) /lang/en | /user/fda_medical_bot | none | |
| 2 | /m/0hqrswg | /medicine/drug_formulation/brand_names | Fluvastatin Sodium ER /lang/en | none | /m/0jwqy4w | |
| 3 | /m/0hqrswg | /common/topic/article | /base/medicaldrugs/fda_load/articlekey_0jvdm41 | none | /m/0jwqy4w | |
| 4 | /m/0hqrswg | /medicine/drug_formulation/manufactured_forms | /base/medicaldrugs/fda_load/mdf_0781_5370_sandoz_PYF7O1FV7F_80_0mg_tablet_extended_release_tablet | none | /m/0jwqy4w | |
| 5 | /m/0hqrswg | /medicine/drug_formulation/reference_form | /m/0hqklkk Lescol XL 80 extended release tablet | none | /user/fda_medical_bot/attr/39 | |
| 6 | /m/0hqrswg | /medicine/drug_formulation/active_ingredient_moieties | /m/02z6yr Fluvastatin | none | /user/fda_medical_bot/attr/25 | |
| 7 | /m/0hqrswg | /medicine/drug_formulation/brand_names | Lescol Xl /lang/en | none | /user/fda_medical_bot/attr/25 | |
| 8 | /m/0hqrswg | /medicine/drug_formulation/formulation_of | /m/0hqx4rq Fluvastatin sodium | none | /user/fda_medical_bot/attr/25 | |
| 9 | /m/0hqrswg | /medicine/drug_formulation/strength | /m/0hydzj8 cvt | none | /user/fda_medical_bot/attr/1 | |
| 10 | /m/0hqrswg | /medicine/drug_formulation/legal_status | /m/01_7r6 Prescription drug | none | /user/fda_medical_bot/attr/1 | |
| 11 | /m/0hqrswg | /medicine/drug_formulation/formulation_of | /m/02z6yr Fluvastatin | none | /user/fda_medical_bot/attr/1 | |
| 12 | /m/0hqrswg | /medicine/drug_formulation/drug_category | /m/02kjb_ Drug | none | /user/fda_medical_bot/attr/1 | |
| 13 | /m/0hqrswg | /medicine/drug_formulation/routes | /m/02nq08g Oral | none | /user/fda_medical_bot/attr/1 | |
| 14 | /m/0hqrswg | /medicine/drug_formulation/dosage_form | /m/0hqy0b7 Extended release tablet | none | /user/fda_medical_bot/attr/1 | |
| 15 | /m/0hqrswg | /medicine/drug_formulation/active_ingredients | /m/0hqx4rq Fluvastatin sodium | none | /user/fda_medical_bot/attr/1 | |
| 16 | /m/0hqrswg | /medicine/drug_formulation/manufactured_forms | /m/0hqklkk Lescol XL 80 extended release tablet | none | /user/fda_medical_bot/attr/1 | |
| 17 | /m/0hqrswg | /medicine/drug_formulation/manufactured_forms | /m/0hqgz45 Lescol Xl 80 extended release tablet | none | /user/fda_medical_bot/attr/1 | |
| 18 | /m/0hqrswg | /type/object/type | /common/topic | none | /user/fda_medical_bot/attr/1 | |
| 19 | /m/0hqrswg | /type/object/type | /medicine/drug_formulation | none | /user/fda_medical_bot/attr/1 | |
| 20 | /m/0hqrswg | /type/object/name | Fluvastatin sodium 80 extended release tablet /lang/en | none | /user/fda_medical_bot/attr/1 | |
| 21 | /m/0hqrswg | /type/object/key | form_PYF7O1FV7F_80_0mg_tablet_extended_release_tablet_oral /base/medicaldrugs/fda_load | none | /user/fda_medical_bot/attr/1 | |
| 22 | /m/0hqrswg | /type/object/permission | /boot/all_permission | none | /user/fda_medical_bot/attr/1 | |
| next | ||||||